Skip to main content
All lobbying filings

ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)

Lobbying for ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.")

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $200,000.00 expenses · posted Apr 16, 2025

Official filing document

 Bills named in this filing 4
 Lobbying activity 3
Health Issues

Issues related to the medical-surgical supply chain including domestic and near-shore production including the Pandemic and All-Hazards Preparedness Act (Public Law No. 109-417); Promoting Resilient Supply Chains Act of 2025 (S. 257).

Medicare/Medicaid

Issues related to patient access to respiratory therapy including non-invasive ventilation and related reimbursement (see the DMEPOS Relief Act of 2025 [H.R. 2005]; the Supplemental Oxygen Access Reform [SOAR] Act of 2024, 118th Congress H.R. 7829, S. 3821); the extension of telehealth flexibilities (see Public Law No. 119-4); and promoting electronic prescribing platforms.

Trade (domestic/foreign)

Issues related to the medical-surgical supply chain including domestic and near-shore production.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem